| Year |
Citation |
Score |
| 2021 |
Serrero G. Progranulin/GP88, A Complex and Multifaceted Player of Tumor Growth by Direct Action and via the Tumor Microenvironment. Advances in Experimental Medicine and Biology. 1329: 475-498. PMID 34664252 DOI: 10.1007/978-3-030-73119-9_22 |
0.436 |
|
| 2021 |
Eckstein M, Lieb V, Jung R, Sikic D, Weigelt K, Stöhr R, Geppert C, Weyerer V, Bertz S, Serrero G, Yue B, Hartmann A, Wullich B, Taubert H, Wach S. Combination of GP88 Expression in Tumor Cells and Tumor-Infiltrating Immune Cells Is an Independent Prognostic Factor for Bladder Cancer Patients. Cells. 10. PMID 34359965 DOI: 10.3390/cells10071796 |
0.363 |
|
| 2021 |
Guha R, Yue B, Dong J, Banerjee A, Serrero G. Anti-progranulin/GP88 antibody AG01 inhibits triple negative breast cancer cell proliferation and migration. Breast Cancer Research and Treatment. PMID 33616772 DOI: 10.1007/s10549-021-06120-y |
0.568 |
|
| 2021 |
Marquez J, Dong J, Dong C, Tian C, Serrero G. Identification of Prostaglandin F2 Receptor Negative Regulator (PTGFRN) as an internalizable target in cancer cells for antibody-drug conjugate development. Plos One. 16: e0246197. PMID 33503070 DOI: 10.1371/journal.pone.0246197 |
0.329 |
|
| 2021 |
Yabe K, Yamamoto Y, Takemura M, Hara T, Tsurumi H, Serrero G, Nabeshima T, Saito K. Progranulin depletion inhibits proliferation via the transforming growth factor beta/SMAD family member 2 signaling axis in Kasumi-1 cells. Heliyon. 7: e05849. PMID 33490663 DOI: 10.1016/j.heliyon.2020.e05849 |
0.342 |
|
| 2019 |
Tkaczuk KHR, Hawkins D, Yue B, Hicks D, Tait N, Serrero G. Association of Serum Progranulin Levels With Disease Progression, Therapy Response and Survival in Patients With Metastatic Breast Cancer. Clinical Breast Cancer. PMID 31928925 DOI: 10.1016/J.Clbc.2019.11.010 |
0.479 |
|
| 2019 |
Abdulrahman A, Eckstein M, Jung R, Guzman J, Weigelt K, Serrero G, Yue B, Geppert C, Stöhr R, Hartmann A, Wullich B, Wach S, Taubert H, Lieb V. Expression of GP88 (Progranulin) Protein Is an Independent Prognostic Factor in Prostate Cancer Patients. Cancers. 11. PMID 31888257 DOI: 10.3390/cancers11122029 |
0.358 |
|
| 2019 |
Marquez J, Dong C, Dong J, Yue B, Serrero G. Abstract 210: Novel antibody drug conjugate to inhibit mesothelioma tumor growth Cancer Research. 79: 210-210. DOI: 10.1158/1538-7445.Am2019-210 |
0.447 |
|
| 2018 |
Greither T, Fischer K, Theil G, Marcou M, Holzhausen HJ, Weigelt K, Serrero G, Hicks D, Yue B, Fornara P, Wullich B, Taubert H, Wach S, Lieb V. Expression of GP88 (progranulin) in serum of prostate cancer patients is associated with Gleason scores and overall survival. Cancer Management and Research. 10: 4173-4180. PMID 30323673 DOI: 10.2147/CMAR.S172069 |
0.438 |
|
| 2018 |
Serrero G, Hicks D. Immunohistochemical Detection of Progranulin (PGRN/GP88/GEP) in Tumor Tissues as a Cancer Prognostic Biomarker. Methods in Molecular Biology (Clifton, N.J.). 1806: 107-120. PMID 29956272 DOI: 10.1007/978-1-4939-8559-3_8 |
0.406 |
|
| 2018 |
Serrero G, Hicks D. Measurement of Circulating Progranulin (PGRN/GP88/GEP) by Enzyme-Linked Immunosorbent Assay and Application in Human Diseases. Methods in Molecular Biology (Clifton, N.J.). 1806: 95-105. PMID 29956271 DOI: 10.1007/978-1-4939-8559-3_7 |
0.407 |
|
| 2018 |
Guha R, Dong J, Yue B, Serrero G. Abstract 1934: Anti-Progranulin (GP88) antibody AG01 therapeutic effect in triple negative breast cancer invasiveness Cancer Research. 78: 1934-1934. DOI: 10.1158/1538-7445.Am2018-1934 |
0.623 |
|
| 2017 |
Serrero G, Hawkins D, Ioffe O, Bejarano P, Yue B. Abstract 677: Progranulin/GP88 tumor tissue expression further stratifies survival outcomes of patients classified by their Nottingham Prognostic Index Cancer Research. 77: 677-677. DOI: 10.1158/1538-7445.Am2017-677 |
0.366 |
|
| 2016 |
Serrero G. Potential of Theranostic Target Mining in the Development of Novel Diagnostic and Therapeutic Products in Oncology: Progranulin/GP88 as a Therapeutic and Diagnostic Target for Breast and Lung Cancers. Rinsho Byori. the Japanese Journal of Clinical Pathology. 64: 1296-1309. PMID 30695312 |
0.408 |
|
| 2016 |
Kim JH, Do IG, Kim K, Sohn JH, Kim HJ, Jeon WK, Lee SR, Son BH, Shin JH, Nam H, Kwon HJ, Kim MS, Hong HP, Serrero G, Koo DH, et al. Progranulin as a predictive factor of response to chemotherapy in advanced biliary tract carcinoma. Cancer Chemotherapy and Pharmacology. PMID 27744566 DOI: 10.1007/s00280-016-3170-z |
0.338 |
|
| 2016 |
Serrero G, Hawkins DM, Bejarano PA, Ioffe O, Tkaczuk KR, Elliott RE, Head JF, Phillips J, Godwin AK, Weaver J, Hicks D, Yue B. Determination of GP88 (progranulin) expression in breast tumor biopsies improves the risk predictive value of the Nottingham Prognostic Index. Diagnostic Pathology. 11: 71. PMID 27501955 DOI: 10.1186/S13000-016-0520-4 |
0.449 |
|
| 2016 |
Serrero G, Hicks D, Yue B, Hawkins DM, Tait N, Tkaczuk KH. Abstract 3918: Circulating progranulin (GP88/PGRN) level correlates with survival in metastatic breast cancer patients Cancer Research. 76: 3918-3918. DOI: 10.1158/1538-7445.Am2016-3918 |
0.495 |
|
| 2015 |
Kim WE, Yue B, Serrero G. Signaling Pathway of GP88 (Progranulin) in Breast Cancer Cells: Upregulation and Phosphorylation of c-myc by GP88/Progranulin in Her2-Overexpressing Breast Cancer Cells. Breast Cancer : Basic and Clinical Research. 9: 71-7. PMID 27168723 DOI: 10.4137/BCBCR.S29371 |
0.49 |
|
| 2015 |
Tkaczuk KH, Campassi C, Kesmodel S, Bellavance E, Olson J, Nichols E, Feigenberg SJ, Yue B, Hicks D, Serrero G. Abstract OT2-4-01: A prospective study of glycoprotein 88 GP-88 blood test in healthy women with Gail model risk <=1.66 undergoing screening for breast cancer (BC) with mammography (MM) Cancer Research. 75. DOI: 10.1158/1538-7445.Sabcs14-Ot2-4-01 |
0.382 |
|
| 2015 |
Serrero G, Edelman MJ, Bejarano P, Hawkins DM, Hicks D, Reisman DN, Ioffe O, Feliciano J, Yue B. Abstract 4339: Progranulin (GP88) expression in thoracic maligancies Cancer Research. 75: 4339-4339. DOI: 10.1158/1538-7445.Am2015-4339 |
0.478 |
|
| 2014 |
Edelman MJ, Feliciano J, Yue B, Bejarano P, Ioffe O, Reisman D, Hawkins D, Gai Q, Hicks D, Serrero G. GP88 (progranulin): a novel tissue and circulating biomarker for non-small cell lung carcinoma. Human Pathology. 45: 1893-9. PMID 25033727 DOI: 10.1016/J.Humpath.2014.05.011 |
0.386 |
|
| 2014 |
Tangkeangsirisin W, Serrero G. GP88 (Progranulin) Confers Fulvestrant (Faslodex, ICI 182,780) Resistance to Human Breast Cancer Cells Advances in Breast Cancer Research. 3: 68-78. DOI: 10.4236/ABCR.2014.33010 |
0.713 |
|
| 2014 |
Serrero G, Dong J, Marquez J, Yue B, Hayashi J. Abstract 4514A: Antibody to Progranulin (Anti-GP88) potentiates tamoxifen and letrozole effect in estrogen receptor positive breast cancer cells Cancer Research. 74. DOI: 10.1158/1538-7445.Am2014-4514A |
0.664 |
|
| 2013 |
Serrero G, Xia G, Dong J, Yue B, Schech A, Hawkins D, Reisman D, Bejarano P, Hayashi J. Abstract 2054: GP88 (Progranulin) is a therapeutic and prognostic target for Non-Small Cell Lung Carcinoma. Cancer Research. 73: 2054-2054. DOI: 10.1158/1538-7445.Am2013-2054 |
0.552 |
|
| 2012 |
Serrero G, Hawkins DM, Yue B, Ioffe O, Bejarano P, Phillips JT, Head JF, Elliott RL, Tkaczuk KR, Godwin AK, Weaver J, Kim WE. Progranulin (GP88) tumor tissue expression is associated with increased risk of recurrence in breast cancer patients diagnosed with estrogen receptor positive invasive ductal carcinoma. Breast Cancer Research : Bcr. 14: R26. PMID 22316048 DOI: 10.1186/Bcr3111 |
0.486 |
|
| 2012 |
Serrero G, Dong J, Hayashi J. Abstract 2515: Anti- GP88 (progranulin) antibody to GP88 (progranulin) inhibits breast tumor growth and restores sensitivity to tamoxifen Cancer Research. 72: 2515-2515. DOI: 10.1158/1538-7445.Am2012-2515 |
0.685 |
|
| 2012 |
Serrero G, Dong J, Hayashi J. Abstract P6-04-19: Neutralizing antibody to human GP88 (progranulin) restores sensitivity to tamoxifen and inhibits breast tumor growth in mouse xenografts Cancer Research. 72. DOI: 10.1158/0008-5472.Sabcs12-P6-04-19 |
0.681 |
|
| 2012 |
Serrero G, Koka M, Goicochea L, Tkaczuk K, Fernandez K, Logan L, Tuttle K, Yue B, Ioffe O. Abstract P2-10-40: Correlation between expression of the prognostic marker Progranulin (GP88) with Oncotype Dx Recurrence Score in estrogen receptor positive breast tumors Cancer Research. 72. DOI: 10.1158/0008-5472.Sabcs12-P2-10-40 |
0.613 |
|
| 2011 |
Serrero G, Hawkins DM, Yue B, Ioffe OB, Bejarano P, Phillips JT, Head JF, Elliott RL, Godwin AK, Weaver J, Kim W, Kamimura S. Association of GP88 (progranulin) tumor expression with decreased disease-free and overall survivals in patients with breast cancer with estrogen receptor-positive invasive ductal carcinoma. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 604. PMID 28021184 DOI: 10.1200/Jco.2011.29.15_Suppl.604 |
0.65 |
|
| 2011 |
Tkaczuk KR, Yue B, Zhan M, Tait N, Yarlagadda L, Dai H, Serrero G. Increased Circulating Level of the Survival Factor GP88 (Progranulin) in the Serum of Breast Cancer Patients When Compared to Healthy Subjects. Breast Cancer : Basic and Clinical Research. 5: 155-62. PMID 21792312 DOI: 10.4137/BCBCR.S7224 |
0.575 |
|
| 2011 |
Abrhale T, Brodie A, Sabnis G, Macedo L, Tian C, Yue B, Serrero G. GP88 (PC-Cell Derived Growth Factor, progranulin) stimulates proliferation and confers letrozole resistance to aromatase overexpressing breast cancer cells. Bmc Cancer. 11: 231. PMID 21658239 DOI: 10.1186/1471-2407-11-231 |
0.685 |
|
| 2011 |
Serrero G, Hawkins DM, Yue B, Bejarano P, Ioffe O, Phillips J, Head JF, Elliott RL, Kamimura S. Abstract 2275: GP88 (progranulin) tissue expression correlates with increased risk of recurrence for estrogen receptor positive invasive ductal carcinoma Cancer Research. 71: 2275-2275. DOI: 10.1158/1538-7445.Am2011-2275 |
0.579 |
|
| 2011 |
Serrero G, Hawkins D, Ioffe O, Bejarano P, Phillips J, Head J, Elliott R, Godwin A, Weaver J, Yue B. P2-12-32: Association between Progranulin (GP88) Expression and Recurrence Risk for Breast Cancer Patients with Estrogen Receptor Positive Invasive Ductal Carcinoma. Cancer Research. 71. DOI: 10.1158/0008-5472.Sabcs11-P2-12-32 |
0.558 |
|
| 2010 |
Gai QW, Edelman MJ, Ecklund D, Yue B, Kamimura S, Hawkins D, Horiba MN, Battafarano R, Serrero G. Increased circulating level of the autocrine growth factor GP88 (PC cell-derived growth factor factor/progranulin) in early- and advanced-stage non-small cell lung cancer and small cell lung cancer. Journal of Clinical Oncology. 28: e18103-e18103. DOI: 10.1200/Jco.2010.28.15_Suppl.E18103 |
0.479 |
|
| 2010 |
Xia G, Kamimura S, Yue B, Dong J, Serrero G. Abstract 4113: Role of GP88 (Progranulin) in the proliferation and survival of non small cell lung carcinoma Cancer Research. 70: 4113-4113. DOI: 10.1158/1538-7445.Am10-4113 |
0.58 |
|
| 2009 |
Serrero G, Tkaczuk K, Zhan M, Tait N, Ilan C, Eklund D, Yue B. Association of serum levels of the growth factor GP88 with disease progression in breast cancer patients. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 27: e22021. PMID 27963129 DOI: 10.1200/jco.2009.27.15_suppl.e22021 |
0.609 |
|
| 2009 |
Lovat F, Bitto A, Xu SQ, Fassan M, Goldoni S, Metalli D, Wubah V, McCue P, Serrero G, Gomella LG, Baffa R, Iozzo RV, Morrione A. Proepithelin is an autocrine growth factor for bladder cancer. Carcinogenesis. 30: 861-8. PMID 19237611 DOI: 10.1093/Carcin/Bgp050 |
0.532 |
|
| 2009 |
Monami G, Emiliozzi V, Bitto A, Lovat F, Xu SQ, Goldoni S, Fassan M, Serrero G, Gomella LG, Baffa R, Iozzo RV, Morrione A. Proepithelin regulates prostate cancer cell biology by promoting cell growth, migration, and anchorage-independent growth. The American Journal of Pathology. 174: 1037-47. PMID 19179604 DOI: 10.2353/Ajpath.2009.080735 |
0.45 |
|
| 2009 |
Serrero G, Tkaczuk K, Zhan M, Tait N, Ilan C, Yue B. Elevated serum levels of the growth factor GP88 are found in breast cancer patients when compared to healthy individuals. Cancer Research. 69: 2006. DOI: 10.1158/0008-5472.Sabcs-2006 |
0.627 |
|
| 2009 |
Serrero G, Kim W, Ioffe O, Bejarano P, Yue B. Tissue expression of the growth factor GP88 is a predictor of recurrence in patients with estrogen receptor positive breast tumors. Cancer Research. 69: 1088. DOI: 10.1158/0008-5472.Sabcs-1088 |
0.632 |
|
| 2009 |
Serrero G, Tkaczuk K, Yue B, Kamimura S, Tait N, Zhan M, Ecklund D. GP88 Serum Level Is Increased in Breast Cancer Patients with Disease Progression. Cancer Research. 69: 6040-6040. DOI: 10.1158/0008-5472.Sabcs-09-6040 |
0.626 |
|
| 2009 |
Serrero G, Brodie A, Sabnis G, Macedo L, Abrhale T. The Growth Factor GP88 (Progranulin) Confers Aromatase Inhibitor Resistance to Breast Cancer Cells. Cancer Research. 69: 4171-4171. DOI: 10.1158/0008-5472.Sabcs-09-4171 |
0.664 |
|
| 2009 |
Morrione A, Lovat F, Monami G, Bitto A, Xu S, Fassan M, Serrero G, Baffa R, Iozzo RV, Gomella LG. PROEPITHELIN IS A NOVEL BIOMARKER FOR PROSTATE CANCER AND REGULATES CELL GROWTH, MIGRATION AND ANCHORAGE-INDEPENDENT GROWTH OF PROSTATE CANCER CELLS Journal of Urology. 181: 512-512. DOI: 10.1016/S0022-5347(09)61445-2 |
0.413 |
|
| 2008 |
Serrero G, Kim W, Yue B, Ioffe O, Barton R. Prognostic significance of GP88 for breast cancer recurrence Journal of Clinical Oncology. 26: 22064-22064. DOI: 10.1200/JCO.2008.26.15_SUPPL.22064 |
0.516 |
|
| 2006 |
Kim WE, Serrero G. PC cell-derived growth factor stimulates proliferation and confers Trastuzumab resistance to Her-2-overexpressing breast cancer cells. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 12: 4192-9. PMID 16857791 DOI: 10.1158/1078-0432.Ccr-05-2663 |
0.693 |
|
| 2006 |
Wang W, Hayashi J, Serrero G. PC cell-derived growth factor confers resistance to dexamethasone and promotes tumorigenesis in human multiple myeloma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 12: 49-56. PMID 16397023 DOI: 10.1158/1078-0432.Ccr-05-0929 |
0.557 |
|
| 2006 |
Serrero G, Tkaczuk K, Tait N, Golubeva O, Dai H, Feldman FS, Jones L. Circulating levels of the breast cancer growth factor GP88 in the serum of breast cancer (BC) patients Journal of Clinical Oncology. 24: 20050-20050. DOI: 10.1200/JCO.2006.24.18_SUPPL.20050 |
0.601 |
|
| 2005 |
Serrero G, Tkaczuk KH, Jones L, Goloubeva O, Tait NS, Feldman FS, Dai H. PC-cell derived growth factor (PCDGF/GP88): A novel circulating biomarker in breast cancer (BC) patients. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 23: 551. PMID 27946451 DOI: 10.1200/jco.2005.23.16_suppl.551 |
0.63 |
|
| 2004 |
Tangkeangsirisin W, Serrero G. PC cell-derived growth factor (PCDGF/GP88, progranulin) stimulates migration, invasiveness and VEGF expression in breast cancer cells. Carcinogenesis. 25: 1587-92. PMID 15117809 DOI: 10.1093/Carcin/Bgh171 |
0.727 |
|
| 2004 |
Tangkeangsirisin W, Hayashi J, Serrero G. PC cell-derived growth factor mediates tamoxifen resistance and promotes tumor growth of human breast cancer cells. Cancer Research. 64: 1737-43. PMID 14996734 DOI: 10.1158/0008-5472.Can-03-2364 |
0.724 |
|
| 2004 |
Pan CX, Kinch MS, Kiener PA, Langermann S, Serrero G, Sun L, Corvera J, Sweeney CJ, Li L, Zhang S, Baldridge LA, Jones TD, Koch MO, Ulbright TM, Eble JN, et al. PC cell-derived growth factor expression in prostatic intraepithelial neoplasia and prostatic adenocarcinoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 10: 1333-7. PMID 14977833 DOI: 10.1158/1078-0432.Ccr-1123-03 |
0.32 |
|
| 2003 |
Serrero G, Ioffe OB. Expression of PC-cell-derived growth factor in benign and malignant human breast epithelium. Human Pathology. 34: 1148-54. PMID 14652816 DOI: 10.1016/S0046-8177(03)00425-8 |
0.576 |
|
| 2003 |
Serrero G. Autocrine growth factor revisited: PC-cell-derived growth factor (progranulin), a critical player in breast cancer tumorigenesis. Biochemical and Biophysical Research Communications. 308: 409-13. PMID 12914763 DOI: 10.1016/S0006-291X(03)01452-9 |
0.573 |
|
| 2003 |
Wang W, Hayashi J, Kim WE, Serrero G. PC cell-derived growth factor (granulin precursor) expression and action in human multiple myeloma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 9: 2221-8. PMID 12796389 |
0.343 |
|
| 2003 |
Jones MB, Michener CM, Blanchette JO, Kuznetsov VA, Raffeld M, Serrero G, Emmert-Buck MR, Petricoin EF, Krizman DB, Liotta LA, Kohn EC. The granulin-epithelin precursor/PC-cell-derived growth factor is a growth factor for epithelial ovarian cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 9: 44-51. PMID 12538450 |
0.381 |
|
| 2001 |
Serrero G, Lu R. Effect of resveratrol on the expression of autocrine growth modulators in human breast cancer cells Antioxidants and Redox Signaling. 3: 969-979. PMID 11813992 DOI: 10.1089/152308601317203512 |
0.582 |
|
| 2001 |
Lu R, Serrero G. Mediation of estrogen mitogenic effect in human breast cancer MCF-7 cells by PC-cell-derived growth factor (PCDGF/granulin precursor) Proceedings of the National Academy of Sciences. 98: 142-147. DOI: 10.1073/Pnas.98.1.142 |
0.519 |
|
| 2000 |
Lu R, Serrero G. Inhibition of PC cell-derived growth factor (PCDGF, epithelin/granulin precursor) expression by antisense PCDGF cDNA transfection inhibits tumorigenicity of the human breast carcinoma cell line MDA-MB-468. Proceedings of the National Academy of Sciences of the United States of America. 97: 3993-8. PMID 10760271 DOI: 10.1073/Pnas.97.8.3993 |
0.62 |
|
| 1999 |
Gao J, Serrero G. Adipose differentiation related protein (ADRP) expressed in transfected COS-7 cells selectively stimulates long chain fatty acid uptake. The Journal of Biological Chemistry. 274: 16825-30. PMID 10358026 DOI: 10.1074/Jbc.274.24.16825 |
0.313 |
|
| 1999 |
Lu R, Serrero G. Resveratrol, a natural product derived from grape, exhibits antiestrogenic activity and inhibits the growth of human breast cancer cells. Journal of Cellular Physiology. 179: 297-304. PMID 10228948 DOI: 10.1002/(Sici)1097-4652(199906)179:3<297::Aid-Jcp7>3.0.Co;2-P |
0.55 |
|
| 1999 |
Lu R, Serrero G. Stimulation of PC cell-derived growth factor (epithelin/granulin precursor) expression by estradiol in human breast cancer cells. Biochemical and Biophysical Research Communications. 256: 204-7. PMID 10066447 DOI: 10.1006/Bbrc.1999.0253 |
0.543 |
|
| 1998 |
Zhang H, Serrero G. Inhibition of tumorigenicity of the teratoma PC cell line by transfection with antisense cDNA for PC cell-derived growth factor (PCDGF, epithelin/granulin precursor). Proceedings of the National Academy of Sciences of the United States of America. 95: 14202-7. PMID 9826678 DOI: 10.1073/Pnas.95.24.14202 |
0.482 |
|
| 1998 |
Xia X, Serrero G. Identification of cell surface binding sites for PC-cell-derived growth factor, PCDGF, (epithelin/granulin precursor) on epithelial cells and fibroblasts. Biochemical and Biophysical Research Communications. 245: 539-43. PMID 9571191 DOI: 10.1006/Bbrc.1998.8498 |
0.374 |
|
| 1993 |
Zhou J, Serrero G. Fibroblast growth factor inhibits proliferation of a highly tumorigenic insulin-independent teratoma-derived cell line. Growth Factors (Chur, Switzerland). 9: 123-31. PMID 8217215 DOI: 10.3109/08977199309010827 |
0.374 |
|
| 1992 |
Jiang HP, Serrero G. Isolation and characterization of a full-length cDNA coding for an adipose differentiation-related protein. Proceedings of the National Academy of Sciences of the United States of America. 89: 7856-60. PMID 1518805 DOI: 10.1073/Pnas.89.17.7856 |
0.311 |
|
| 1981 |
Barnes D, Wolfe R, Serrero G, McClure D, Sato G. Effects of a serum spreading factor on growth and morphology of cells in serum-free medium. Journal of Supramolecular Structure. 14: 47-63. PMID 6163926 DOI: 10.1002/JSS.400140106 |
0.312 |
|
| Show low-probability matches. |